Durvalumab vs Lamotrigine

Durvalumab vs Lamotrigine: Overview

This comparison examines the pharmacological differences between Durvalumab and Lamotrigine.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Lamotrigine: Sodium channel blocker inhibiting glutamate release.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Lamotrigine — 25 hours.

Chemical Properties

Molecular Formula: Lamotrigine — C9H7Cl2N5.

Molecular Weight: Lamotrigine — 256.0910 g/mol.

Type: Durvalumab — Antibody; Lamotrigine — Small molecule.